Literature DB >> 12951050

Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation.

Masahiro Sasaki1, Jason Anast, William Bassett, Toshifumi Kawakami, Noriaki Sakuragi, Rajvir Dahiya.   

Abstract

Methylation-specific PCR (MSP) is frequently used to distinguish methylated alleles in the genome. Sequences that have been incompletely converted during bisulfite treatment are frequently co-amplified during MSP. For accurate MSP, it is important to detect methylated sequences in a background of unconverted DNA with a high level of sensitivity. We report here sensitive techniques, bisulfite conversion-specific MSP (BS-MSP) to accurately evaluate CpG methylation. BS-MSP provides accurate results across a wide spectrum of bisulfite conversion levels. BS-MSP is also confirmed to be a useful technique for the routine analysis of clinical tumor specimens that were paraffin-embedded and microdissected. BS-MSP thus provides the powerful features of ease of use and compatibility with paraffin sections. We recommend that methylation analysis should include a step to eliminate unconverted DNA to avoid overestimation of the DNA methylation level in the samples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951050     DOI: 10.1016/j.bbrc.2003.08.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma.

Authors:  Wei Guo; Lei Cui; Cong Wang; Yanli Guo; Supeng Shen; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2014-04-23       Impact factor: 5.150

2.  RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Cong Wang; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2015-01-13       Impact factor: 5.150

3.  Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.

Authors:  Wei Guo; Zhiming Dong; Jianli Cui; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang
Journal:  Clin Exp Metastasis       Date:  2016-01       Impact factor: 5.150

4.  Role of DNA methylation in the regulation of the RANKL-OPG system in human bone.

Authors:  Jesús Delgado-Calle; Carolina Sañudo; Agustín F Fernández; Raúl García-Renedo; Mario F Fraga; José A Riancho
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

5.  Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.

Authors:  Wei Guo; Shengnan Liu; Zhiming Dong; Yanli Guo; Chunyan Ding; Supeng Shen; Jia Liang; Baoen Shan
Journal:  Clin Exp Metastasis       Date:  2018-03-10       Impact factor: 5.150

6.  Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Tienian Zhu; Zhiming Dong; Lei Cui; Minghui Zhang; Gang Kuang
Journal:  Clin Exp Metastasis       Date:  2013-06-21       Impact factor: 5.150

7.  Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.

Authors:  Yibing Liu; Zhiming Dong; Jia Liang; Yanli Guo; Xin Guo; Supeng Shen; Gang Kuang; Wei Guo
Journal:  Tumour Biol       Date:  2015-11-17

Review 8.  Epigenetics in bladder cancer.

Authors:  Hideki Enokida; Masayuki Nakagawa
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

9.  Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Yabin Shi; Shengnan Liu; Jia Liang; Yanli Guo; Xin Guo; Supeng Shen; Guiying Wang
Journal:  Clin Exp Metastasis       Date:  2016-05-17       Impact factor: 5.150

Review 10.  Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.

Authors:  Dalbir S Sandhu; Abdirashid M Shire; Lewis R Roberts
Journal:  Liver Int       Date:  2007-11-21       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.